RNA-mediated toxicity in C9orf72 ALS and FTD

被引:29
|
作者
McEachin, Zachary T. [1 ,2 ]
Parameswaran, Janani [1 ]
Raj, Nisha [1 ,2 ]
Bassell, Gary J. [1 ,2 ,3 ]
Jiang, Jie [1 ]
机构
[1] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA
[2] Emory Univ, Lab Translat Cell Biol, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
关键词
Amyotrophic lateral sclerosis; Frontotemporal dementia; C9orf72; RNA-mediated toxicity; RNA foci; Dipeptide repeat proteins; Antisense oligonucleotide; FRONTOTEMPORAL LOBAR DEGENERATION; DIPEPTIDE REPEAT PROTEINS; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; PATHOLOGICAL FEATURES; ANTISENSE RNA; MUSCLEBLIND PROTEINS; TDP-43; PATHOLOGY; SMALL MOLECULES; IN-VITRO;
D O I
10.1016/j.nbd.2020.105055
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A GGGGCC hexanucleotide repeat expansion in the first intron of C9orf72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. Compelling evidence suggests that gain of toxicity from the bidirectionally transcribed repeat expanded RNAs plays a central role in disease pathogenesis. Two potential mechanisms have been proposed including RNA-mediated toxicity and/or the production of toxic dipeptide repeat proteins. In this review, we focus on the role of RNA mediated toxicity in ALS/FTD caused by the C9orf72 mutation and discuss arguments for and against this mechanism. In addition, we summarize how G4C2 repeat RNAs can elicit toxicity and potential therapeutic strategies to mitigate RNA-mediated toxicity.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
    Martier, Raygene
    Liefhebber, Jolanda M.
    Garcia-Osta, Ana
    Miniarikova, Jana
    Cuadrado-Tejedor, Mar
    Espelosin, Maria
    Ursua, Susana
    Petry, Harald
    van Deventer, Sander J.
    Evers, Melvin M.
    Konstantinova, Pavlina
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 16 : 26 - 37
  • [2] Moderate intrinsic phenotypic alterations in C9orf72 ALS/FTD iPSC-microglia despite the presence of C9orf72 pathological features
    Lorenzini, Ileana
    Alsop, Eric
    Levy, Jennifer
    Gittings, Lauren M.
    Lall, Deepti
    Rabichow, Benjamin E.
    Moore, Stephen
    Pevey, Ryan
    Bustos, Lynette M.
    Burciu, Camelia
    Bhatia, Divya
    Singer, Mo
    Saul, Justin
    McQuade, Amanda
    Tzioras, Makis
    Mota, Thomas A.
    Logemann, Amber
    Rose, Jamie
    Almeida, Sandra
    Gao, Fen-Biao
    Marks, Michael
    Donnelly, Christopher J.
    Hutchins, Elizabeth
    Hung, Shu-Ting
    Ichida, Justin
    Bowser, Robert
    Spires-Jones, Tara
    Blurton-Jones, Mathew
    Gendron, Tania F.
    Baloh, Robert H.
    Van Keuren-Jensen, Kendall
    Sattler, Rita
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [3] Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
    Kumar, Vijay
    Hasan, Gulam M.
    Hassan, Md. Imtaiyaz
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [4] RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
    Donnelly, Christopher J.
    Zhang, Ping-Wu
    Pham, Jacqueline T.
    Heusler, Aaron R.
    Mistry, Nipun A.
    Vidensky, Svetlana
    Daley, Elizabeth L.
    Poth, Erin M.
    Hoover, Benjamin
    Fines, Daniel M.
    Maragakis, Nicholas
    Tienari, Pentti J.
    Petrucelli, Leonard
    Traynor, Bryan J.
    Wang, Jiou
    Rigo, Frank
    Bennett, C. Frank
    Blackshaw, Seth
    Sattler, Rita
    Rothstein, Jeffrey D.
    NEURON, 2013, 80 (02) : 415 - 428
  • [5] Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS/FTD
    Schmitz, Alexander
    Pinheiro Marques, Joao
    Oertig, Irina
    Maharjan, Niran
    Saxena, Smita
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [6] An amyloid-like cascade hypothesis for C9orf72 ALS/FTD
    Edbauer, Dieter
    Haass, Christian
    CURRENT OPINION IN NEUROBIOLOGY, 2016, 36 : 99 - 106
  • [7] RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
    Ramesh, Nandini
    Daley, Elizabeth L.
    Gleixner, Amanda M.
    Mann, Jacob R.
    Kour, Sukhleen
    Mawrie, Darilang
    Anderson, Eric N.
    Kofler, Julia
    Donnelly, Christopher J.
    Kiskinis, Evangelos
    Pandey, Udai Bhan
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2020, 8 (01)
  • [8] C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
    O'Rourke, Jacqueline G.
    Bogdanik, Laurent
    Muhammad, A. K. M. G.
    Gendron, Tania F.
    Kim, Kevin J.
    Austin, Andrew
    Cady, Janet
    Liu, Elaine Y.
    Zarrow, Jonah
    Grant, Sharday
    Ho, Ritchie
    Bell, Shaughn
    Carmona, Sharon
    Simpkinson, Megan
    Lall, Deepti
    Wu, Kathryn
    Daughrity, Lillian
    Dickson, Dennis W.
    Harms, Matthew B.
    Petrucelli, Leonard
    Lee, Edward B.
    Lutz, Cathleen M.
    Baloh, Robert H.
    NEURON, 2015, 88 (05) : 892 - 901
  • [9] A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
    Esanov, Rustam
    Cabrera, Gabriela Toro
    Andrade, Nadja S.
    Gendron, Tania F.
    Brown, Robert H., Jr.
    Benatar, Michael
    Wahlestedt, Claes
    Mueller, Christian
    Zeier, Zane
    MOLECULAR NEURODEGENERATION, 2017, 12
  • [10] Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD
    Zhang, Ke
    Grima, Jonathan C.
    Rothstein, Jeffery D.
    Lloyd, Thomas E.
    NUCLEUS, 2016, 7 (02) : 132 - 137